A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
D000493:Allopurinol / Q000378:metabolism / Q000627:therapeutic use*; D001706:Biopsy; D006073:Gout / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007042:Hypoxanthines / Q000378:metabolism; D013058:Mass Spectrometry; D009132:Muscles / Q000378:metabolism*; D011687:Purines / Q000378:metabolism*; D011720:Pyrazoles / Q000378:metabolism; D011743:Pyrimidines / Q000378:metabolism*; D014527:Uric Acid / Q000378:metabolism; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors; D014970:Xanthines / Q000378:metabolism
D007042:Hypoxanthines; D011687:Purines; D011720:Pyrazoles; D011743:Pyrimidines; D014970:Xanthines; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase